Roivant Sciences Ltd. Common Shares vs Health Care Select Sector SPDR Fund — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while Health Care Select Sector SPDR Fund trades at $170.75 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is the larger of the two by market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| ROIV | XLV | |
|---|---|---|
Market Cap | $24.72B | $43.48B |
Volume | 6,279,442 | 11,121,431 |
Sector | Health | — |
52-Week High | $41.81 | $175.68 |
52-Week Low | $16.04 | $141.95 |
Typical Hold Time | 1 Days | 100 Days |
Enterprise Value | $20.99B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLV trades at $170.81, up 1.18% with a bearish technical signal from moving averages. The ETF's low 0.08% expense ratio and healthcare sector diversification provide defensive positioning amid market volatility. Recent options activity shows increased put volume, indicating some investor caution despite healthcare's traditional defensive characteristics during economic uncertainty.
Healthcare sector ETFs like XLV offer defensive exposure with potential upside from demographic trends and innovation. Key risks include political volatility around healthcare policy and concentration in large-cap US stocks. The ETF's cost efficiency and sector positioning make it attractive for long-term investors seeking healthcare exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →